Shelton Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.92M Sell
147,026
-85,567
-37% -$4.99M 0.2% 112
2025
Q4
$12.5M Sell
232,593
-148,295
-39% -$7.13M 0.25% 93
2025
Q3
$17.2M Buy
380,888
+12,925
+4% +$604K 0.37% 62
2025
Q2
$17M Sell
367,963
-91,108
-20% -$4.47M 0.39% 53
2025
Q1
$28M Buy
459,071
+243,887
+113% +$14.2M 0.67% 28
2024
Q4
$12.2M Buy
215,184
+105,101
+95% +$5.87M 0.3% 81
2024
Q3
$5.7M Sell
110,083
-9,071
-8% -$426K 0.15% 139
2024
Q2
$4.95M Sell
119,154
-1,301
-1% -$58.2K 0.13% 147
2024
Q1
$6.53M Sell
120,455
-5,598
-4% -$285K 0.19% 127
2023
Q4
$6.47M Sell
126,053
-8,753
-6% -$459K 0.2% 114
2023
Q3
$7.82M Sell
134,806
-2,198
-2% -$135K 0.29% 83
2023
Q2
$8.76M Sell
137,004
-32,798
-19% -$2.2M 0.31% 68
2023
Q1
$11.8M Buy
169,802
+134,002
+374% +$9.45M 0.49% 39
2022
Q4
$2.58M Sell
35,800
-79,258
-69% -$5.98M 0.27% 128
2022
Q3
$8.18M Buy
115,058
+18,640
+19% +$1.35M 0.39% 71
2022
Q2
$7.42M Sell
96,418
-5,603
-5% -$427K 0.33% 76
2022
Q1
$7.45M Buy
102,021
+42,247
+71% +$2.84M 0.28% 87
2021
Q4
$3.73M Sell
59,774
-38,200
-39% -$2.24M 0.13% 167
2021
Q3
$5.8M Buy
97,974
+40,380
+70% +$2.66M 0.23% 101
2021
Q2
$3.85M Buy
57,594
+32,000
+125% +$2.09M 0.15% 155
2021
Q1
$1.62M Sell
25,594
-693
-3% -$43.1K 0.06% 258
2020
Q4
$1.63M Sell
26,287
-156,730
-86% -$9.64M 0.07% 223
2020
Q3
$11M Buy
183,017
+156,692
+595% +$9.43M 0.46% 41
2020
Q2
$1.55M Buy
26,325
+468
+2% +$28K 0.09% 206
2020
Q1
$1.44M Hold
25,857
0.1% 183
2019
Q4
$1.66M Sell
25,857
-3,008
-10% -$172K 0.09% 187
2019
Q3
$1.46M Sell
28,865
-200
-0.7% -$9.4K 0.09% 189
2019
Q2
$1.32M Buy
29,065
+27,626
+1,920% +$1.29M 0.08% 208
2019
Q1
$30.2K Sell
1,439
-29,326
-95% -$1.46M 0.12% 172
2018
Q4
$1.6M Sell
30,765
-2,900
-9% -$156K 0.11% 165
2018
Q3
$2.09M Buy
33,665
+490
+1% +$29.1K 0.12% 148
2018
Q2
$1.84M Buy
33,175
+1,230
+4% +$66.4K 0.11% 164
2018
Q1
$2.02M Sell
31,945
-500
-2% -$32.2K 0.13% 152
2017
Q4
$1.99M Hold
32,445
0.13% 155
2017
Q3
$2.07M Sell
32,445
-400
-1% -$23.4K 0.14% 146
2017
Q2
$1.83M Buy
32,845
+900
+3% +$49K 0.13% 155
2017
Q1
$1.74M Sell
31,945
-400
-1% -$21.9K 0.12% 153
2016
Q4
$1.89M Sell
32,345
-11,250
-26% -$615K 0.14% 149
2016
Q3
$2.35M Sell
43,595
-7,860
-15% -$505K 0.2% 97
2016
Q2
$3.79M Buy
51,455
+6,512
+14% +$460K 0.33% 64
2016
Q1
$2.87M Buy
44,943
+510
+1% +$32.2K 0.26% 82
2015
Q4
$3.06M Buy
44,433
+4,284
+11% +$283K 0.3% 70
2015
Q3
$2.38M Hold
40,149
0.26% 79
2015
Q2
$2.67M Buy
40,149
+10,900
+37% +$718K 0.28% 75
2015
Q1
$1.89M Sell
29,249
-934
-3% -$58.5K 0.2% 108
2014
Q4
$1.78M Sell
30,183
-630
-2% -$35.5K 0.21% 99
2014
Q3
$1.58M Buy
30,813
+1,000
+3% +$50K 0.21% 97
2014
Q2
$1.45M Hold
29,813
0.2% 100
2014
Q1
$1.55M Hold
29,813
0.23% 93
2013
Q4
$1.58M Sell
29,813
-1,300
-4% -$66.2K 0.24% 89
2013
Q3
$1.44M Hold
31,113
0.24% 90
2013
Q2
$1.39M Buy
+31,113
New +$1.35M 0.25% 87

Other funds holding BMY

Shelton Capital Management's BMY Position: Q1 2026 in Review

Shelton Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 37% in Q1 2026, selling an estimated $4.99M and leaving 147,026 shares worth $8.92M. The position accounts for 0.2% of the portfolio, ranked #112.

Shelton Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $28M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Shelton Capital Management held 147,026 shares of Bristol-Myers Squibb worth $8.92M as of Q1 2026.
  • Shelton Capital Management sold 85,567 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.99M.
  • Bristol-Myers Squibb made up 0.2% of Shelton Capital Management's portfolio in Q1 2026, its #112 holding.
  • Shelton Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Shelton Capital Management's Bristol-Myers Squibb position peaked at $28M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.